Zusammenfassung
Im Juli 2022 ist mit der Version 2.0 das erste Update der deutschen interdisziplinären S3-Leitlinie für die Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom, gefördert durch das Leitlinienprogramm Onkologie erschienen. Dieser Artikel ist die Zusammenfassung des Kap. 6: „Operative Therapie“. Wesentliche Neuerungen gegenüber der Version 1.0 sind die Einführung der molekularen Klassifikation zur Risikoabschätzung und damit gezielteren individualisierten Therapie, die stadienbasierte Sentinellymphknotenbiopsie sowie die Option der neoadjuvanten Chemotherapie bei primär inoperablen Endometriumkarzinomen.
Abstract
In July 2022, the first update (Version 2.0) of the German S3 guideline on the diagnosis, treatment and follow-up of patients with endometrial cancer was published, supported by the Leitlinienprogramm Onkologie (Oncology Guideline Program). This article is the summary of Chap. 6: “Surgical Treatment”. Relevant innovations compared to version 1.0 include the introduction of molecular classification and sentinel node biopsy, as well as the option of neoadjuvant chemotherapy for advanced cases where primary cytoreductive surgery is not possible.
Literatur
Asher R, Obermair A, Janda M et al (2018) Disease-free and survival outcomes for total laparoscopic hysterectomy compared with total abdominal hysterectomy in early-stage endometrial carcinoma: a meta-analysis. Int J Gynecol Cancer 28:529–538. https://doi.org/10.1097/IGC.0000000000001199
Barlin JN, Puri I, Bristow RE (2010) Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis. Gynecol Oncol 118:14–18. https://doi.org/10.1016/j.ygyno.2010.04.005
Bendifallah S, Koskas M, Ballester M et al (2012) The survival impact of systematic lymphadenectomy in endometrial cancer with the use of propensity score matching analysis. Am J Obstet Gynecol 206:500e1–500e11. https://doi.org/10.1016/j.ajog.2012.03.027
Bodurtha Smith AJ, Fader AN, Tanner EJ (2017) Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 216:459–476e410. https://doi.org/10.1016/j.ajog.2016.11.1033
Body N, Gregoire J, Renaud MC et al (2018) Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer. Gynecol Oncol 150:267–273. https://doi.org/10.1016/j.ygyno.2018.06.001
Bogani G, Casarin J, Roberti Maggiore LU et al (2020) Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: Long-term results of a propensity-matched analysis. Gynecol Oncol 158:77–83. https://doi.org/10.1016/j.ygyno.2020.04.691
Bogani G, Murgia F, Ditto A et al (2019) Sentinel node mapping vs. lymphadenectomy in endometrial cancer: a systematic review and meta-analysis. Gynecol Oncol 153:676–683. https://doi.org/10.1016/j.ygyno.2019.03.254
Chan JK, Wu H, Cheung MK et al (2007) The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol 106:282–288. https://doi.org/10.1016/j.ygyno.2007.05.033
Cosgrove CM, Cohn DE, Rhoades J et al (2019) The prognostic significance of aortic lymph node metastasis in endometrial cancer: potential implications for selective aortic lymph node assessment. Gynecol Oncol 153:505–510. https://doi.org/10.1016/j.ygyno.2019.03.251
Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 60:2035–2041
Cusimano MC, Simpson AN, Dossa F et al (2019) Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: a systematic review and meta-analysis of conversions and complications. Am J Obstet Gynecol 221:410–428.e19. https://doi.org/10.1016/j.ajog.2019.05.004
Cusimano MC, Vicus D, Pulman K et al (2021) Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate- and high-grade endometrial cancer staging. JAMA Surg 156:157–164. https://doi.org/10.1001/jamasurg.2020.5060
de Lange NM, Ezendam NPM, Kwon JS et al (2019) Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer. Curr Oncol 26:e226–e232. https://doi.org/10.3747/co.26.4655
Frost JA, Webster KE, Bryant A et al (2017) Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD007585.pub4
Galaal K, Bryant A, Fisher AD et al (2012) Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006655.pub2
Galaal K, Donkers H, Bryant A et al (2018) Laparoscopy versus laparotomy for the management of early stage endometrial cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD006655.pub3
Garg G, Morris RT, Solomon L et al (2011) Evaluating the significance of location of lymph node metastasis and extranodal disease in women with stage IIIC endometrial cancer. Gynecol Oncol 123:208–213. https://doi.org/10.1016/j.ygyno.2011.07.025
Guo W, Cai J, Li M et al (2018) Survival benefits of pelvic lymphadenectomy versus pelvic and para-aortic lymphadenectomy in patients with endometrial cancer: a meta-analysis. Medicine 97:e9520. https://doi.org/10.1097/MD.0000000000009520
Ind T, Laios A, Hacking M et al (2017) A comparison of operative outcomes between standard and robotic laparoscopic surgery for endometrial cancer: A systematic review and meta-analysis. Int J Med Robot. https://doi.org/10.1002/rcs.1851
Kapp DS, Kiet TK, Chan JK (2011) Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent. Br J Cancer 105:1137–1143. https://doi.org/10.1038/bjc.2011.336
Kogan L, Matanes E, Wissing M et al (2020) The added value of sentinel node mapping in endometrial cancer. Gynecol Oncol 158:84–91. https://doi.org/10.1016/j.ygyno.2020.04.687
Lambrou NC, Gomez-Marin O, Mirhashemi R et al (2004) Optimal surgical cytoreduction in patients with Stage III and Stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol Oncol 93:653–658. https://doi.org/10.1016/j.ygyno.2004.03.015
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom, Langversion 2.0, 2022, AWMF Registernummer: 032/034-OL, http://www.leitlinienprogramm-onkologie.de/leitlinien/endometriumkarzinom/ (In Publikation).
Liu T, Tu H, Li Y et al (2019) Impact of radical hysterectomy versus simple hysterectomy on survival of patients with stage 2 endometrial cancer: a meta-analysis. Ann Surg Oncol 26:2933–2942. https://doi.org/10.1245/s10434-019-07472-y
Morice P, Leary A, Creutzberg C et al (2016) Endometrial cancer. Lancet 387:1094–1108. https://doi.org/10.1016/S0140-6736(15)00130-0
Padilla-Iserte P, Lago V, Tauste C et al (2021) Impact of uterine manipulator on oncological outcome in endometrial cancer surgery. Am J Obstet Gynecol 224:65.e1–65 e11. https://doi.org/10.1016/j.ajog.2020.07.025
Persson J, Salehi S, Bollino M et al (2019) Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. Eur J Cancer 116:77–85. https://doi.org/10.1016/j.ejca.2019.04.025
Philp L, Tannenbaum S, Haber H et al (2021) Effect of surgical approach on risk of recurrence after vaginal brachytherapy in early-stage high-intermediate risk endometrial cancer. Gynecol Oncol 160:389–395. https://doi.org/10.1016/j.ygyno.2020.12.003
Plante M, Stanleigh J, Renaud MC et al (2017) Isolated tumor cells identified by sentinel lymph node mapping in endometrial cancer: does adjuvant treatment matter? Gynecol Oncol 146:240–246. https://doi.org/10.1016/j.ygyno.2017.05.024
Rossi EC, Kowalski LD, Scalici J et al (2017) A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 18:384–392. https://doi.org/10.1016/S1470-2045(17)30068-2
Schlappe BA, Weaver AL, McGree ME et al (2020) Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. Gynecol Oncol 156:62–69. https://doi.org/10.1016/j.ygyno.2019.11.002
Shih KK, Yun E, Gardner GJ et al (2011) Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol 122:608–611. https://doi.org/10.1016/j.ygyno.2011.05.020
Sirisabya N, Manchana T, Worasethsin P et al (2009) Is complete surgical staging necessary in clinically early-stage endometrial carcinoma? Int J Gynecol Cancer 19:1057–1061. https://doi.org/10.1111/IGC.0b013e3181a8ba85
Sueoka K, Umayahara K, Abe A et al (2015) Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy. Int J Gynecol Cancer 25:81–86. https://doi.org/10.1097/IGC.0000000000000268
Tanner EJ, Leitao MM Jr., Garg K et al (2011) The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecol Oncol 123:548–552. https://doi.org/10.1016/j.ygyno.2011.08.020
Versluis MAC, Pielsticker C, van der Aa MA et al (2018) Lymphadenectomy and adjuvant therapy improve survival with uterine carcinosarcoma: a large retrospective cohort study. Oncology 95:100–108. https://doi.org/10.1159/000488531
Wang L, Liu F (2018) Meta-analysis of laparoscopy sentinel lymph node mapping in endometrial cancer. Arch Gynecol Obstet 298:505–510. https://doi.org/10.1007/s00404-018-4845-y
Zheng Y, Yang X, Liang Y et al (2019) Effects of lymphadenectomy among women with stage IA endometrial cancer: a SEER database analysis. Future Oncol 15:2251–2266. https://doi.org/10.2217/fon-2019-0080
Zullo F, Falbo A, Palomba S (2012) Safety of laparoscopy vs laparotomy in the surgical staging of endometrial cancer: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 207:94–100. https://doi.org/10.1016/j.ajog.2012.01.010
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
G. Emons, S.Y. Brucker, M.C. Fleisch, M. Mueller, E. Juhasz-Böss, L. Kiesel, I.B. Runnebaum, M. Friedrich, A. Mustea, S. Erdogan und M.W. Beckmann geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Günter Emons, Göttingen
Teile dieses Beitrags entstammen wörtlich aus dem Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2022) Diagnostik, Therapie und Nachsorge der Patientinnen mit Endometriumkarzinom [23].
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Emons, G., Brucker, S.Y., Fleisch, M.C. et al. Operative Therapie des Endometriumkarzinoms. Gynäkologie 55, 493–500 (2022). https://doi.org/10.1007/s00129-022-04958-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-022-04958-x
Schlüsselwörter
- Hysterektomie
- Lymphonodektomie
- Laparoskopie
- Neoadjuvante Chemotherapie
- Zytoreduktive chirurgische Eingriffe
- Sentinel Node Biopsie